ADC THERAPEUTICS SA shareholders Q4 2022

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 63 filers reported holding ADC THERAPEUTICS SA in Q4 2022. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

ADC THERAPEUTICS SA shareholders Q4 2022
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 1,186,215$4,555,0662.69%
Blue Owl Capital Holdings LP 733,568$2,816,9011.20%
Redmile Group, LLC 7,590,849$29,148,8601.19%
AlphaCentric Advisors LLC 297,500$1,142,4001.13%
Prosight Management, LP 463,310$1,779,1100.97%
GCM Grosvenor Holdings, LLC 735,471$2,824,2090.72%
Indie Asset Partners, LLC 93,839$360,3420.40%
XTX Topco Ltd 197,635$758,9180.16%
Eventide Asset Management 1,879,959$7,219,0430.14%
Nantahala Capital Management 243,290$934,2340.06%
Walleye Capital LLC 513,618$1,972,2930.04%
OCCUDO QUANTITATIVE STRATEGIES LP 61,858$237,5350.03%
Values First Advisors, Inc. 10,400$39,9360.03%
Hennion & Walsh Asset Management, Inc. 58,869$2260.01%
PDT Partners, LLC 15,657$60,1230.01%
Point72 Asset Management, L.P. 704,500$2,705,2800.01%
Magnetar Financial LLC 126,868$4870.01%
MILLENNIUM MANAGEMENT LLC 3,401,120$13,0600.01%
PICTET ASSET MANAGEMENT SA 868,838$3,3360.01%
ALLIANCEBERNSTEIN L.P. 2,824,956$10,847,8310.01%
External links

This page lists ADC THERAPEUTICS SA's shareholders in Q4 2022. To view ADC THERAPEUTICS SA's shareholder history, click here.